Lilly Bounces Into ‘Sell in May’ Territory Amid Pricing Pressure
Eli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
Year By Year Historical Returns Index Funds provides year-by-year results to assess consistency and identify standout years across funds.
25,344 articlesEli Lilly posts above-consensus Q1 results, lifting shares yet leaving the year-to-date narrative pressured by pricin...
A little-known feature of Social Security—the two bend points—tilts benefits toward lower earners, leaving high earne...
As Kolibri wraps its Q4 2025 results, investors seek clarity on growth, margins, and cash flow. This article translat...
As PDD Holdings gears up for its (pdd) 2026 earnings call, investors should focus on growth sustainability, margin pr...
Life360 faces a pivotal year in 2026. This guide breaks down what the Q1 results could reveal about growth, margins, ...
CrowdStrike shares declined about 9% after a fiscal Q1 beat that failed to meet loftier expectations, triggering a br...
Nvidia’s Jensen Huang signals a platform-first moat as Q1 FY27 revenue climbs and data center demand explodes. The co...
Rising sales of probiotics and prebiotics are redefining everyday wellness budgets, while investors watch health and ...
Qualcomm just outlined a much larger growth plan, signaling a strong bet on AI beyond smartphones. This deep dive exp...
Stryker and Intuitive Surgical reported divergent Q1 2026 results, underscoring two distinct medtech playbooks. Stryk...
Micron posts strong AI-driven memory demand and rising cloud bookings, while Apple relies on devices and services to ...
NIO delivered a surprising Q4 2025 GAAP profit and outlined a 2026 path to positive non-GAAP earnings, supported by m...